On our first crossover episode between Unsupervised Learning and Vital Signs, we dove deep into the world of using AI in drug development with Insitro CEO Daphne Koller.
Share this post
How Insitro Is Using AI to Create Better…
Share this post
On our first crossover episode between Unsupervised Learning and Vital Signs, we dove deep into the world of using AI in drug development with Insitro CEO Daphne Koller.